gemcitabine injection

Frequently asked questions

• Onset of action

  The peak effect of this medicine can be observed immediately after intravenous injection.

• Duration of Effect

  The effect of this medicine lasts for an average duration of 2 to 5 hours.

• Safe with Alchohol?

  Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

• Is it habit forming?

  No habit forming tendencies were reported.

• Usage in pregnancy?

  This medicine is not recommended for pregnant women.

• Usage while breast-feeding?

  This medicine is not recommended in breastfeeding women.

• Allergy

  Not recommended in patients with known allergy to Gemcitabine Injection 1 gm 1 Vial

• Pregnancy

  This medicine is not recommended for pregnant women.

• Breast-feeding

  This medicine is not recommended in breastfeeding women.

• Liver injury

  This medicine may cause liver injury and causes death. The liver function parameters need to be assessed before starting the treatment. The treatment should be discontinued if any signs and symptoms of liver injury appear.

• Kidney injury

  This medicine may cause Hemolytic Uremic Syndrome (HUS) which is a serious condition that causes fatalities. The kidney function parameters need to be assessed before starting the treatment. The treatment should be discontinued if any signs and symptoms of kidney injury appear.

• Lung toxicity

  This medicine may cause severe lung injuries like pulmonary fibrosis, pulmonary interstitial infiltrates. Any symptoms of breathing difficulty and signs of lung impairment should be informed to the doctor. The treatment should be discontinued if any symptoms appear.

• Decrease in blood cell count

  This medicine may lower the white blood cell count (neutrophils) and platelets. Close monitoring of blood cell count is necessary. The baseline of the blood cell count should be obtained before initiation of the treatment. Do not start the treatment if the counts are less.

• Infections

  The chances of occurring infections are more in patients receiving this medicine. Hold the chemotherapy and start with the broad-spectrum antibiotics if there are any signs and symptoms of fever. Close monitoring of the body temperature and the blood cell count is necessary.

This medicine is given in multiple cycles. It is important to receive the every scheduled dose and make a note of next scheduled dose. Close monitoring of blood cells counts and lung function is necessary.